Placeholder Banner

Immunovaccine begins trading as “IMV”

October 6, 2009
Immunovaccine Inc. (TSX-V:IMV) will begin trading on the TSX-Venture Exchange as a Tier 1 issuer under the ticker symbol "IMV”. Immunovaccine Inc. also announces the closing of the previously announced private placement totaling $8,269,109 in gross proceeds. The TSX Venture Exchange has accepted the private placement for filing.

 Read the release.